Allergic rhinitis in South Africa: 2012 guidelines

R J Green1, M Hockman, R Friedman

  • 1Department of Paediatrics and Child Health, University of Pretoria, South Africa. robin.green@up.ac.za

Insights

Allergic rhinitis (AR) management in South Africa needs updates, especially for infants. Wise allergy testing and patient education are key for effective AR treatment.

Area of Science:

  • Allergy and Immunology
  • Otorhinolaryngology

Background:

  • Allergic rhinitis (AR) is a significant health concern in South Africa.
  • Previous guidelines by the South African Allergic Rhinitis Working Group (SAARWG) require updates.
  • Key areas needing clarification include infant AR management, allergy testing, cost-effectiveness, differential diagnosis with sinusitis, and over-the-counter medication use.

Purpose of the Study:

  • To provide updated guidance on the diagnosis and management of allergic rhinitis in South Africa.
  • To address specific concerns not adequately covered in previous guidelines.
  • To propose an updated algorithm for AR diagnosis and management.

Main Methods:

  • Review and synthesis of current knowledge and clinical concerns regarding AR.
  • Development of an updated diagnostic and management algorithm.
  • Consideration of local South African context, including allergen prevalence and available treatments.

Main Results:

  • AR is common, impactful, and requires targeted therapy.
  • Recurrent nasal symptoms in infants may indicate AR.
  • Allergy testing should be judiciously applied, focusing on local allergens; total IgE is not routinely necessary.
  • Sinusitis and asthma should be considered alongside AR.
  • Over-the-counter medications require cautious use, with particular attention to topical decongestants.
  • Immunotherapy is a viable option for selected patients in South Africa.

Conclusions:

  • Clinicians must consider AR in infants with persistent nasal symptoms.
  • Judicious use of allergy testing based on local allergens is recommended.
  • Integrated management of AR with sinusitis and asthma is crucial.
  • Patient education is vital for successful AR management.
  • An updated algorithm for AR diagnosis and management is proposed for South Africa.
Abstract

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Upper Respiratory Drugs: First and Second-Generation Antihistamines01:15

Upper Respiratory Drugs: First and Second-Generation Antihistamines

Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Reactions02:06

Allergic Reactions

Overview